SEMA3F and ductal breast carcinoma in situ: Although we cannot exclude the contribution of the inhibition of the TGFβ pathway to this effect, our findings also point toward a new mechanism of SEMA3F proinvasive action in the DCIS-to-IDC transition in BC through both NRP coreceptors, highlighting its demonstrated role in BC progression [85].